Latest News and Press Releases
Want to stay updated on the latest news?
-
Highlights: Placement completed, with oversubscriptions accepted up to $13.9 MillionFidelity Investments follows on to maintain 10.6% ownership of the CompanyIFM Investors and Regal FM to become...
-
Medibio will leverage its proprietary Digital Mental Health platform to process Otsuka clinical data with the goal of further clarifying the role of biomarker-based, objective measures in management...
-
SYDNEY, Australia and MINNEAPOLIS, July 19, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing...
-
SYDNEY, Australia and MINNEAPOLIS, July 05, 2017 (GLOBE NEWSWIRE) -- Australian Stock Exchange listed medical technology company Medibio Limited (MEB or the Company) is pleased to announce the...
-
Scientific breakthrough for non-invasive, automatic, objective diagnosis of PTSD leveraging autonomic biomarkersAccuracy of 80% (+/- 1%) for objectively diagnosing subjects with PTSDMedibio has...
-
SYDNEY, Australia, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (MEB atau Syarikat), iaitu sebuah syarikat teknologi perubatan yang tersenarai dalam ASX yang telah membangunkan ujian...
-
澳大利亚悉尼, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB)（以下简称 "MEB" 或“公司”）——一家在澳洲证券交易所上市的医疗科技公司，为帮助诊断抑郁症、慢性压力及其他的心理健康障碍开发了一套有效的客观测验——今天宣布任命史上获得最多荣誉的游泳运动员及心理健康倡导者为董事。自 2016...
-
SYDNEY, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (MEB หรือ บริษัทฯ) ซึ่งเป็นบริษัทด้านเทคนิคทางการแพทย์ที่จดทะเบียนในตลาดหลักทรัพย์ ASX...
-
SYDNEY, Australia, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB) (MEB atau Perusahaan), perusahaan teknologi medis terdaftar dalam ASX yang telah mengembangkan pengujian objektif yang...
-
澳洲悉尼, June 06, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB)（下文簡稱 「MEB」 或「公司」）——一家在澳洲證券交易所上市的醫療科技公司，為幫助診斷抑鬱症、慢性壓力及其他的心理健康障礙開發了一套有效的客觀測驗——今天宣佈委任史上獲得最多榮譽的游泳運動員及心理健康倡導人加入董事會。 自 2016...